Hu Miao - Search Results

Year	Number of Results
2008	4
2009	2
2010	11
2011	7
2012	16
2013	17
2014	16
2015	15
2016	19
2017	13
2018	14
2019	17
2020	18
2021	28
2022	33
2023	38
2024	12

1

Endothelial Cell-Derived Lactate Triggers Bone Mesenchymal Stem Cell Histone Lactylation to Attenuate Osteoporosis.

Wu J, Hu M, Jiang H, Ma J, Xie C, Zhang Z, Zhou X, Zhao J, Tao Z, Meng Y, Cai Z, Song T, Zhang C, Gao R, Cai C, Song H, Gao Y, Lin T, Wang C, Zhou X. Wu J, et al. Among authors: hu m. Adv Sci (Weinh). 2023 Nov;10(31):e2301300. doi: 10.1002/advs.202301300. Epub 2023 Sep 26. Adv Sci (Weinh). 2023. PMID: 37752768 Free PMC article.

2

Alirocumab for the treatment of hypercholesterolemia.

Tomlinson B, Hu M, Zhang Y, Chan P, Liu ZM. Tomlinson B, et al. Among authors: hu m. Expert Opin Biol Ther. 2017 May;17(5):633-643. doi: 10.1080/14712598.2017.1305354. Epub 2017 Mar 20. Expert Opin Biol Ther. 2017. PMID: 28277798 Review.

3

Artificial intelligence-based radiomics in bone tumors: Technical advances and clinical application.

Meng Y, Yang Y, Hu M, Zhang Z, Zhou X. Meng Y, et al. Among authors: hu m. Semin Cancer Biol. 2023 Oct;95:75-87. doi: 10.1016/j.semcancer.2023.07.003. Epub 2023 Jul 26. Semin Cancer Biol. 2023. PMID: 37499847 Review.

4

A risk scoring system to predict the individual incidence of early-onset colorectal cancer.

Gu J, Li Y, Yu J, Hu M, Ji Y, Li L, Hu C, Wei G, Huo J. Gu J, et al. Among authors: hu m. BMC Cancer. 2022 Jan 29;22(1):122. doi: 10.1186/s12885-022-09238-4. BMC Cancer. 2022. PMID: 35093005 Free PMC article. Review.

5

Pharmacogenomics of lipid-lowering therapies.

Hu M, Tomlinson B. Hu M, et al. Pharmacogenomics. 2013 Jun;14(8):981-95. doi: 10.2217/pgs.13.71. Pharmacogenomics. 2013. PMID: 23746191 Review.

6

Robust estimation of bacterial cell count from optical density.

Beal J, Farny NG, Haddock-Angelli T, Selvarajah V, Baldwin GS, Buckley-Taylor R, Gershater M, Kiga D, Marken J, Sanchania V, Sison A, Workman CT; iGEM Interlab Study Contributors. Beal J, et al. Commun Biol. 2020 Sep 17;3(1):512. doi: 10.1038/s42003-020-01127-5. Commun Biol. 2020. PMID: 32943734 Free PMC article.

7

Lipid-lowing pharmacogenomics in Chinese patients.

Hu M, Tomlinson B. Hu M, et al. Expert Rev Cardiovasc Ther. 2013 Aug;11(8):985-97. doi: 10.1586/14779072.2013.814839. Epub 2013 Aug 16. Expert Rev Cardiovasc Ther. 2013. PMID: 23952137 Review.

8

Current status of familial hypercholesterolemia in Chinese populations.

Tomlinson B, Hu M, Chow E. Tomlinson B, et al. Among authors: hu m. Curr Opin Lipidol. 2019 Apr;30(2):94-100. doi: 10.1097/MOL.0000000000000580. Curr Opin Lipidol. 2019. PMID: 30649024 Review.

9

Safety of statins: an update.

Hu M, Cheung BM, Tomlinson B. Hu M, et al. Ther Adv Drug Saf. 2012 Jun;3(3):133-44. doi: 10.1177/2042098612439884. Ther Adv Drug Saf. 2012. PMID: 25083232 Free PMC article. Review.

10

Pharmacokinetic evaluation of lanreotide.

Hu M, Tomlinson B. Hu M, et al. Expert Opin Drug Metab Toxicol. 2010 Oct;6(10):1301-12. doi: 10.1517/17425255.2010.513700. Expert Opin Drug Metab Toxicol. 2010. PMID: 20716034 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

250 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

250 results

Results by year